SAN CARLOS, Calif.,
Feb. 19, 2020 /PRNewswire/
-- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in
cell-free DNA testing, today announced that it will release results
for its fourth quarter and year ended December 31, 2019, after the market close on
February 26, 2020. Natera will host a
conference call and webcast at 1:30 p.m.
PT (4:30 p.m. ET) to discuss
its financial results, business activities, and financial
outlook.
Earnings Conference Call Information:
Event:
|
Natera's Fourth
Quarter and Year-End 2019 Financial Results
|
Date:
|
Wednesday, February
26, 2020
|
Time:
|
1:30 p.m. PT (4:30
p.m. ET)
|
Live Dial-In:
|
(877) 823-0171,
Domestic
(617) 500-6932, International
|
Conference
ID:
|
9992859
|
Webcast:
|
https://edge.media-server.com/mmc/p/hab8jim9
|
A webcast replay will be available at investor.natera.com.
About Natera
Natera is a global leader in
cell-free DNA testing. The mission of the company is to change the
management of disease worldwide with a focus on reproductive
health, oncology, and organ transplantation. Natera operates an ISO
13485-certified and CAP-accredited laboratory certified under the
Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, Calif. It offers proprietary
genetic testing services to inform physicians who care for pregnant
women, transplant physicians, oncologists, and cancer researchers,
including biopharmaceutical companies, and genetic laboratories
through its cloud-based software platform. For more information,
visit natera.com. Follow Natera on LinkedIn.
Contacts
Investor Relations: Mike Brophy, CFO, Natera, Inc., 650-249-9090
Media: Paul Greenland,
pr@natera.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/natera-announces-fourth-quarter-and-fiscal-2019-earnings-conference-call-301008056.html
SOURCE Natera, Inc.